DOCSLIB.ORG

Minerva Catalogue

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Minerva Catalogue 2016 Catalogue 2017 Food & Water Assays PCR Cycler Validation Contract Nucleic Acid Manufacturing Extraction Cell Culture Contamination DNA Standards & Control Cleaning Products Introduction Facts Minerva Biolabs, founded in 1999, is a privately owned company. Our office and manufacturing fa- cilities are located in Berlin, Germany. The company is part of the Dilarus Group, a privately owned holding company, that is providing product design and communication services to the group mem- bers. Further group members are the Mera Scientific GmbH, a distributor of internationally avaliable molecular diagnostic technologies to the German market, and the Minerva Analytix GmbH, a GMP- certified QC lab for biopharmaceutical and ATMP release testing. Our Assets We serve our customers with our dedicated and well-trained distribution partners in more than 50 countries across the five continents. We lead in the niche markets with solutions for EP 2.6.7-compliant mycoplasma contamination test- ing, meat identification testing, vegan food control, PCR cycler qualification, and validation standards to give just a selection of our innovative product portfolio. All these products feature the latest PCR technology. We bring high-value solutions to our customers through our expertise and longstanding experience reflected in our products and contract manufacturing services. If you are looking for an expert and flexible partner for the preparation of your molecular biology kit or reagent, Minerva Biolabs is the right choice. Automated liquid-handling, freeze-drying technology and clean room facilities are avail- able to comply with any customer demand. We serve academic and industrial cell culture laboratories, quality control units in biopharmaceutical industry as well as food quality professionals providing a service for faster, reliable and stress-free technologies for their specific needs. We do not stop with single applications like PCR but aim to provide integrated solutions that are required for handling cell cultures contamination-free with our elimination and disinfection reagents, or for operating PCR labs contamination-free with our DNA and RNA removal reagents as well as monitoring tools. We bring experiences and services to markets that are undersupplied by the major industry players that provide mainly products without support. Customized guidance is our strength as we develop products and apply them routinely in our labs. Based on our experiences, we seek to further improve our products and develop new products to offer innovative solutions to our customer, which keeps Minerva Biolabs on a constant path of growth. We are highly committed to quality and implemented a quality management system that was certi- fied according to ISO 9001 in the first business year. Since 2007, we conduct our business according to ISO 13485 which enables us to manufacture IVDs according to the in-vitro diagnostic directive. Many customer and authority audits proved the conformity of our quality management system. 2 3 Cell Culture PCR Cycler Food & Water Nucleic Acid DNA Standards & Contract Control Validation Assays Extraction Cleaning Products Manufacturing Bestellinformationen Ordering Information Wir nehmen Ihre Bestellungen gerne über unseren Wieviel kostet der Versand? All customers may order via our online shop, by e- Free shipping for qualified orders Onlineshop, per E-Mail, per Fax oder telefonisch ent- Wir berechnen in Deutschland für alle Versendun- mail, fax, or telephone. For customers outside of Within Germany, shipping charges are 10.50 Euro gegen. Ausländische Kunden können sich direkt an gen regulär 10,50 Euro. Alle Bestellungen mit einem Germany, please contact the Minerva Biolabs’ dis- for standard shipment. Minerva Biolabs will pay the unsere Vertriebspartner wenden. Diese stellen auch Bestellwert von mehr als 300 Euro sind versandkos- tributor within your country. If your country does not shipping charges for any order within Germany that Preisinformationen zur Verfügung. tenfrei. Für Bestellungen aus dem Ausland fallen die have an authorized distributor, our online shop will totals 300 Euro or more. Please inquire about costs effektiven Versandkosten an. guide you. for international shipments at info@minerva-biolabs. Telefon: +49 (0)30 2000437-0 com. Fax: +49 (0)30 2000437-9 Wann wird die Ware geliefert? Telefon: +49 (0)30 2000437-0 Web: www.minerva-biolabs.com Wir liefern Bestellungen bis 12.00 Uhr noch am sel- Fax: +49 (0)30 2000437-9 Same day shipping E-Mail: [email protected] ben Tag aus. Die Ware trifft innerhalb von 1-3 Werkta- Web: www.minerva-biolabs.com Orders will be shipped the same day until 12 AM, un- Shop: http://shop.minerva-biolabs.com gen bei Ihnen ein. Weniger robuste Produkte, wie z.B. E-mail: [email protected] less otherwise stated or requested. Non-perishables die Polymerasen, werden normalerweise nicht am Shop: http://shop.minerva-biolabs.com can be shipped from Monday to Friday. To assure pro- Informationen, die Sie für eine Bestellung benö- Freitag versendet, um ihre Integrität zu garantieren. duct integrity, less robust products like polymerases tigen Bitte kontaktieren Sie Minerva Biolabs für besonde- Information to provide with your order normally are not shipped on Friday. However, please 1 Ihren Namen, Telefonnummer re Vereinbarungen. 1 Name, telephone number, and e-mail contact Minerva Biolabs for special arrangements. und E-Mail- Adresse Bei Lieferverzögerungen werden Sie natürlich umge- address In case of a delay in delivery we will inform you im- 2 Institut/Firma hend benachrichtigt. Auf Anfrage senden wir Ihnen 2 Company/institute mediately. If requested we will send you the confir- 3 Liefer- und ggf. Rechnungsadresse unverzüglich eine Auftragsbestätigung zu. Wir behal- 3 Shipping and billing address mation of your order without delay. 4 ggf. Ihre Auftragsnummer ten uns vor, Produktspezifikationen und Preise ohne 4 Purchase order number Prices are subject to change without notice. Please con- 5 Bestellnummer Vorankündigung zu ändern. Preise und Spezifikatio- 5 Catalog number firm current pricing at the time of your order. 6 Produktname, Packungsgröße und Menge nen bestätigen wir gerne auf Anfrage. 6 Product name, size, and quantity For more detailed information, Zahlungsbedingungen Weitere Fragen beantworten wir Ihnen gerne und Terms of payment please contact: Zahlungsziel ist 14 Tage nach Rechnungserhalt ohne schnell unter: Terms of payment is 14 days after receipt of invoice. E-mail: [email protected] Abzug. Die Ware bleibt bis zur vollständigen Bezah- E-Mail: [email protected] The goods remain our property until payment of the Phone: +49 (0)30 2000 4370 lung unser Eigentum. Es gelten die Allgemeinen Ge- Telefon: +49 (0)30 2000 4370 invoice. The terms and conditions apply. schäftsbedingungen. Official mailing address Postanschrift Our VAT No. Minerva Biolabs GmbH Unsere Umsatzsteuernummer Minerva Biolabs GmbH DE199467805 Koepenicker Strasse 325 DE199467805 Köpenicker Straße 325 12555 Berlin D-12555 Berlin Germany Technische Anfragen Technical Support Für viele unserer Produkte bieten wir ergänzende In- mit einer individuellen und kompetenten Betreu- For many of our products, we are able to provide ad- petent support. Please use for your inquiry our form formationen auf unserer Webseite an. Bitte rufen Sie ung zur Verfügung und unterstützen Sie gerne bei ditional information on our website. Please access on the website http://www.minerva-biolabs.com/en/ die jeweilige Produktseite auf und achten Sie auf die Schwierigkeiten jeglicher Art. Bitte verwenden Sie für the respective product page and have a look at the contact. Einträge an der rechten Seite. Ihre Anfrage unser Formular auf der Webseite http:// links on the right side. If this information does not Sollten diese Informationen Ihnen nicht weiter- www.minerva-biolabs.com/de/kontakt. help you, please contact our support team. They helfen, stehen wir unseren Kunden natürlich gerne are glad to assist you with an individual and com- 4 5 Cell Culture PCR Cycler Food & Water Nucleic Acid DNA Standards & Contract Control Validation Assays Extraction Cleaning Products Manufacturing Cell Culture Contamination Control 8 Meat ID™ Kits 54 ExtractNow™ Meat ID 55 Introduction 10 Meat ID™ Screen 56 Meat ID™ Halal 57 Mycoplasma Detection Kits 12 Venor®GeM Classic 13 Vegan Control™ Kits 58 Venor®GeM Advance 14 ExtractNow™ Vegan Control 59 Venor®GeM OneStep 15 Vegan Control™ OneStep 60 Venor®GeM qEP 16 Vegan Control™ Advance 61 Venor®GeM Sample Preparation Kit 17 10CFU™ Mycoplasma Sensitivity Standards 18 Nucleic Acid Extraction 62 Mycoplasma Elimination Reagents 20 ExtractNow™ Plasmid Mini Kit 64 Mynox® 22 ExtractNow™ DNA Mini Kit 65 Mynox® Gold 23 ExtractNow™ Blood DNA Mini Kit 66 ExtractNow™ RNA Mini Kit 67 Onar® Bacteria – Bacteria Detection Kit 24 ExtractNow™ CleanUp Kit 68 Decontamination, Disinfection, and Prevention 26 ExtractNow™ Virus DNA/RNA Kit 69 ZellShield® 27 Mycoplasma-Off™ 28 DNA Standards and Cleaning 70 Mycoplasma-Off™ Wipes 29 WaterShield™ 30 DNA Standards 72 MB Taq DNA Polymerase 31 Specifity Standards 72 Genomic DNA Extracts 72 PCR Cycler Validation 32 PCR Quantification Standards 74 10CFU™ 76 Introduction 34 Cleaning 78 PCR Cycler Check™ 35 PCR Clean™ Spray 79 qPCR Cycler Check™ 36 PCR Clean™ Wipes 80 Color Compensation Kit 37 Lab Clean™ 81 WaterShield™ 82 Food and Water Testing 38 AquaScreen® 40 Contract Manufacturing 84 AquaScreen® FastExtract 42 AquaScreen® Legionella species 43 Appendix 88 AquaScreen®
Load more

Recommended publications
  • Lpr0050 and Lpr0024 in Legionella Pneumophila
    Characterization of the role of the small regulatory RNA (sRNAs) lpr0050 and lpr0024 in Legionella pneumophila Malak Sadek Natural Resource Sciences Department McGill University Montreal, Canada Supervisor: Prof. Sébastien P. Faucher June , 2019 A thesis submitted to McGill University in partial fulfillment of the requirements of the degree of Master of Science © Malak Sadek 2019 1 Abstract Legionella pneumophila is a facultative intracellular pathogen, and it is the causative agent of Legionnaires’ disease, a life-threatening form of pneumonia. L. pneumophila is commonly found in most water systems including freshwater bodies, rivers, and lakes as well as in engineered water systems and man-made water distribution systems such as cooling towers. Free-living amoeba in aquatic environments are the primary reservoir of L. pneumophila. Following inhalation of contaminated water droplets by humans, L. pneumophila infects and replicates within lung alveolar macrophages and potentially causes Legionnaires’ disease (LD) in susceptible individuals. The bacterium establishes its intracellular niche by forming the Legionella-containing vacuoles (LCVs). L. pneumophila governs the formation of the LCV and intracellular growth through the Icm/Dot type IVB secretion system. Icm/Dot is able to translocate around 300 protein effectors in the host cell allowing L. pneumophila to modulate many signalling and metabolic pathways of the host to its benefit. It is believed that Small Regulatory RNAs (sRNAs) are major players of regulation of virulence-related genes in L. pneumophila. We investigated the regulatory role of the two sRNA Lpr0050 and Lpr0024. Lpr0050 is encoded on the complementary strand of the effector SdeA. Using northern blot we showed that the cis-encoded sRNALpr0050 is expressed in the Exponential (E) phase and Post-Exponential (PE) phase in the wild-type, ΔcpxR and ΔletS.
    [Show full text]
  • List of the Pathogens Intended to Be Controlled Under Section 18 B.E
    (Unofficial Translation) NOTIFICATION OF THE MINISTRY OF PUBLIC HEALTH RE: LIST OF THE PATHOGENS INTENDED TO BE CONTROLLED UNDER SECTION 18 B.E. 2561 (2018) By virtue of the provision pursuant to Section 5 paragraph one, Section 6 (1) and Section 18 of Pathogens and Animal Toxins Act, B.E. 2558 (2015), the Minister of Public Health, with the advice of the Pathogens and Animal Toxins Committee, has therefore issued this notification as follows: Clause 1 This notification is called “Notification of the Ministry of Public Health Re: list of the pathogens intended to be controlled under Section 18, B.E. 2561 (2018).” Clause 2 This Notification shall come into force as from the following date of its publication in the Government Gazette. Clause 3 The Notification of Ministry of Public Health Re: list of the pathogens intended to be controlled under Section 18, B.E. 2560 (2017) shall be cancelled. Clause 4 Define the pathogens codes and such codes shall have the following sequences: (1) English alphabets that used for indicating the type of pathogens are as follows: B stands for Bacteria F stands for fungus V stands for Virus P stands for Parasites T stands for Biological substances that are not Prion R stands for Prion (2) Pathogen risk group (3) Number indicating the sequence of each type of pathogens Clause 5 Pathogens intended to be controlled under Section 18, shall proceed as follows: (1) In the case of being the pathogens that are utilized and subjected to other law, such law shall be complied. (2) Apart from (1), the law on pathogens and animal toxin shall be complied.
    [Show full text]
  • Antigenic Heterogeneity Among Legionella, Fluoribacter, and Tatlockia Species Analyzed by Crossed Immunoelectrophoresis
    INTERNATIONALJOURNAL OF SYSTEMATICBACTERIOLOGY, Oct. 1987, p. 351-356 Vol. 37, No. 4 0020-7713/87/040351-06$02.00/0 Copyright 0 1987, International Union of Microbiological Societies Antigenic Heterogeneity Among Legionella, Fluoribacter, and Tatlockia Species Analyzed by Crossed Immunoelectrophoresis MICHAEL T. COLLINS,l* JETTE M. BANGSBORG,2 AND NIELS H@IBY2 Department of Pathobiological Sciences, University of Wisconsin, Madison, Wisconsin 53706’ and State Serum Institute, Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark2 Crossed immunoelectrophoresis (XIE) reference systems were established for Fluoribacter (Legionella) (containing Fluoribacter bozemanae, Fluoribacter dumofii, and Fluoribacter gormanii) and for Tatlockia (Legionella) micdadei. The Fluoribacter and Tatlockia XIE reference systems contained 54 and 72 anode- migrating antigens, respectively. These two systems, together with the previously described polyvalent Legionella pneumophila (serogroups 1 through 6) XIE reference system, were used to study the cross- reactivities of antigens from organisms comprising the three proposed genera in the family Legionellaceae. Antigenic homology was expressed as the matching coefficient (MC), the ratio of the number of cross-reactive antigens to the total number of antigens. The MCs for individual L. pneumophila serogroups when the polyvalent L. pneumophila antibody was used were 0.98 f 0.05, which was significantly higher than the MCs determined by using Fluoribacter or Tatlockia antibodies (0.50 f 0.13) (P < 0.001). The MCs for the three species of Fluoribacter when polyvalent Fluoribacter antibody was used were 0.93 & 0.10, which was also significantly higher than the MCs when heterologous antibodies were used (0.40 f 0.04) (P< 0.001). The MCs for T.
    [Show full text]
  • Pesnyakevich.Pdf
    щ УДК 579.61(075.8)+579.63(075.8) ББК 52.64я73+51.201.7я73 П28 Рецензенты: кафедра биотехнологии и биоэкологии Белорусского государственного технологическго университета (заведующий кафедрой кандидат химических наук, доцент В. Н. Леонтьев); кандидат биологических наук, доцент Н. А. Белясова; кандидат биологических наук, доцент Л. Н. Валентович Песнякевич, А. Г. П28 Медицинская и санитарная микробиология : учеб. пособие / А. Г. Пес- някевич. – Минск, 2017. – 231 с. ISBN 978-985-566-452-0. Рассматриваются инфекционный процесс как взаимодействие патогена и ор- ганизма-хозяина, патогенность и вирулентность как общие свойства возбудите- лей инфекционных заболеваний, факторы патогенности и вирулентности болезне- творных бактерий и их действие на клеточно-молекулярном уровне. Описываются общие принципы борьбы с инфекционными заболеваниями, а также основы про- филактики и терапии инфекционных болезней. Приводятся современные сведения о систематическом положении возбудителей инфекционных заболеваний бактери- альной этиологии и вызываемых ими инфекционных процессах. Предназначено для студентов, обучающихся в учреждениях высшего образова- ния по специальностям «Биология (по направлениям)», «Микробиология». УДК 579.61(075.8)+579.63(075.8) ББК 52.64я73+51.201.7я73 ISBN 978-985-566-452-0 © Песнякевич А. Г., 2017 © БГУ, 2017 ВВЕДЕНИЕ Предлагаемое учебное пособие написано согласно программе, утверж- денной для студентов биологического факультета Белорусского государ- ственного университета. По этой причине в книге отсутствуют общие све дения о строении, физиологии и экологии микроорганизмов, а также о строении и функционировании иммунной системы млекопитающих, уже известные студентам пятого года обучения из общих курсов «Ми- кробиология» и «Основы иммунологии». Кроме того, в разделе «Частная медицинская микробиология» рассматриваются только бактериальные возбудители инфекционных заболеваний человека, поскольку о па тоген- ных грибах и вирусах студенты биофака БГУ узнают из других курсов, читаемых на факультете.
    [Show full text]
  • The Role of Lipids in Legionella-Host Interaction
    International Journal of Molecular Sciences Review The Role of Lipids in Legionella-Host Interaction Bozena Kowalczyk, Elzbieta Chmiel and Marta Palusinska-Szysz * Department of Genetics and Microbiology, Institute of Biological Sciences, Faculty of Biology and Biotechnology, Maria Curie-Sklodowska University, Akademicka St. 19, 20-033 Lublin, Poland; [email protected] (B.K.); [email protected] (E.C.) * Correspondence: [email protected] Abstract: Legionella are Gram-stain-negative rods associated with water environments: either nat- ural or man-made systems. The inhalation of aerosols containing Legionella bacteria leads to the development of a severe pneumonia termed Legionnaires’ disease. To establish an infection, these bacteria adapt to growth in the hostile environment of the host through the unusual structures of macromolecules that build the cell surface. The outer membrane of the cell envelope is a lipid bilayer with an asymmetric composition mostly of phospholipids in the inner leaflet and lipopolysaccha- rides (LPS) in the outer leaflet. The major membrane-forming phospholipid of Legionella spp. is phosphatidylcholine (PC)—a typical eukaryotic glycerophospholipid. PC synthesis in Legionella cells occurs via two independent pathways: the N-methylation (Pmt) pathway and the Pcs pathway. The utilisation of exogenous choline by Legionella spp. leads to changes in the composition of lipids and proteins, which influences the physicochemical properties of the cell surface. This phenotypic plastic- ity of the Legionella cell envelope determines the mode of interaction with the macrophages, which results in a decrease in the production of proinflammatory cytokines and modulates the interaction with antimicrobial peptides and proteins. The surface-exposed O-chain of Legionella pneumophila sg1 LPS consisting of a homopolymer of 5-acetamidino-7-acetamido-8-O-acetyl-3,5,7,9-tetradeoxy-L- glycero-D-galacto-non-2-ulosonic acid is probably the first component in contact with the host cell that anchors the bacteria in the host membrane.
    [Show full text]
  • CGM-18-001 Perseus Report Update Bacterial Taxonomy Final Errata
    report Update of the bacterial taxonomy in the classification lists of COGEM July 2018 COGEM Report CGM 2018-04 Patrick L.J. RÜDELSHEIM & Pascale VAN ROOIJ PERSEUS BVBA Ordering information COGEM report No CGM 2018-04 E-mail: [email protected] Phone: +31-30-274 2777 Postal address: Netherlands Commission on Genetic Modification (COGEM), P.O. Box 578, 3720 AN Bilthoven, The Netherlands Internet Download as pdf-file: http://www.cogem.net → publications → research reports When ordering this report (free of charge), please mention title and number. Advisory Committee The authors gratefully acknowledge the members of the Advisory Committee for the valuable discussions and patience. Chair: Prof. dr. J.P.M. van Putten (Chair of the Medical Veterinary subcommittee of COGEM, Utrecht University) Members: Prof. dr. J.E. Degener (Member of the Medical Veterinary subcommittee of COGEM, University Medical Centre Groningen) Prof. dr. ir. J.D. van Elsas (Member of the Agriculture subcommittee of COGEM, University of Groningen) Dr. Lisette van der Knaap (COGEM-secretariat) Astrid Schulting (COGEM-secretariat) Disclaimer This report was commissioned by COGEM. The contents of this publication are the sole responsibility of the authors and may in no way be taken to represent the views of COGEM. Dit rapport is samengesteld in opdracht van de COGEM. De meningen die in het rapport worden weergegeven, zijn die van de auteurs en weerspiegelen niet noodzakelijkerwijs de mening van de COGEM. 2 | 24 Foreword COGEM advises the Dutch government on classifications of bacteria, and publishes listings of pathogenic and non-pathogenic bacteria that are updated regularly. These lists of bacteria originate from 2011, when COGEM petitioned a research project to evaluate the classifications of bacteria in the former GMO regulation and to supplement this list with bacteria that have been classified by other governmental organizations.
    [Show full text]
  • Identification Et Caractérisation De Composés Produits Par Des Bactéries Environnementales Pour La Lutte Biologique Contre Legionella Pneumophila Marie-Hélène Corre
    Identification et caractérisation de composés produits par des bactéries environnementales pour la lutte biologique contre Legionella pneumophila Marie-Hélène Corre To cite this version: Marie-Hélène Corre. Identification et caractérisation de composés produits par des bactéries environ- nementales pour la lutte biologique contre Legionella pneumophila. Chimie analytique. Université de Poitiers, 2018. Français. NNT : 2018POIT2309. tel-02461235 HAL Id: tel-02461235 https://tel.archives-ouvertes.fr/tel-02461235 Submitted on 30 Jan 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THESE Pour l’obtention du Grade de DOCTEUR DE L’UNIVERSITE DE POITIERS FACULTE DES SCIENCES FONDAMENTALES ET APPLIQUEES (Diplôme National - Arrêté du 25 mai 2016) Ecole Doctorale : Gay Lussac – Sciences pour l'environnement Secteur de Recherche : Aspects moléculaires et cellulaires de la biologie - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Identification et caractérisation de composés produits par des
    [Show full text]
  • Legionella and Non-Tuberculous Mycobacteria Using MALDI TOF MS (Matrix Assisted Laser Desorption Ionisation Time of Flight Mass Spectrometry)
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by OTHES DIPLOMARBEIT Titel der Diplomarbeit Establishment of a reference database for Acanthamoeba, Legionella and non-tuberculous mycobacteria using MALDI TOF MS (Matrix Assisted Laser Desorption Ionisation Time of Flight Mass Spectrometry) Verfasserin Dzenita HASANACEVIC angestrebter akademischer Grad Magistra der Naturwissenschaften (Mag.rer.nat.) Wien, 2012 Studienkennzahl lt. A 442 Studienblatt: Studienrichtung lt. Studienblatt: Anthropologie Betreuerin: Ass. Prof. Univ. Doz. Mag. Dr. Julia Walochnik Contents 1 ABBREVIATIONS ..................................................................................................... 5 2 INTRODUCTION ....................................................................................................... 6 2.1 Acanthamoeba .................................................................................................... 6 2.1.1 Classification ................................................................................................ 6 2.1.1.1 Phylogeny of Acanthamoeba ................................................................. 6 2.1.1.2 Methods of classification ....................................................................... 8 2.1.2 Ecology and geographical distribution ........................................................ 11 2.1.2.1 Life cycle ............................................................................................. 11 2.1.2.2 Trophozoites ......................................................................................
    [Show full text]
  • Methods Development for Unregulated Contaminants in Drinking Water
    Method Development for Unregulated Contaminants in Drinking Water: Public Meeting and Webinar Held June 6, 2018 USEPA, Office of Ground Water and Drinking Water Office of Water (MLK 140) EPA 815-A-18-001 June 2018 Methods Development for Unregulated Contaminants in Drinking Water Methods Development for Unregulated Contaminants in Drinking Water Public Meeting and Webinar June 6, 2018 9:00 a.m. ‐ 3:00 p.m. ET U.S. EPA Office of Water and Office of Research and Development Welcome & SDWA Regulatory Process Brenda Parris, U.S. EPA Office of Ground Water and Drinking Water Technical Support Center Page 1 of 103 Methods Development for Unregulated Contaminants in Drinking Water Participating by Webinar • Listen‐only mode Figure 1 • Click on “+” next to “Questions” in the control panel (Figure 1) to submit questions/comments Figure 2 • Type a question in the box; click send (Figure 2) • Submit questions as soon as possible • Questions will be answered at the end of the presentations June 2018 U.S. Environmental Protection Agency Slide 3 of 206 Agenda 8:30‐9:00 Stakeholder Sign‐In Welcome & SDWA Regulatory Process Overview of Method Development EPA Method 542 EPA Methods 524.2/524.3/524.4 and 525.3 EPA Method 556.1 ~10:15‐10:30 Break EPA Method 540 & 543 EPA Methods 537 & 538 Method in Development: PFAS Method in Development 558: Ethyl carbamate (Urethane) and N‐Methyl‐2‐pyrrolidone Method in Development: Nonylphenols ~11:45‐12:45 Lunch Method in Development: Legionella Method in Development: Mycobacterium ~1:45‐2:00 Break 2:00‐3:00 Open Forum and Discussion Closing Remarks Page 2 of 103 Methods Development for Unregulated Contaminants in Drinking Water Overview • Regulatory background for UCMR • Safe Drinking Water Act (SDWA) authority • Relationships to: • Contaminant Candidate List (CCL) • Unregulated Contaminant Monitoring Rule (UCMR) • Regulatory Determination • Six‐Year Review June 2018 U.S.
    [Show full text]
  • Water-Borne Infections in Hospitals and Their Prevention - No Water Is Worse Than Still Water
    Water-borne infections in hospitals and their prevention - no water is worse than still water Egil Lingaas Department of Infection Prevention, Oslo University Hospital, Norway Oslo University Hospital Department of Infection Prevention 03/2016 Egil Lingaas Legionella 54 species and 74 antigenic types Widespread in environment in low numbers Water and humid environments Compost Ca. 20 species have caused human infection Most common (> 90 %): Legionella pneumophila Legionella micdadei ca 2 % Legionella bozemanae ca 2 % Int J Syst Evol Microbiol 2010;62:2946 Oslo University Hospital Department of Infection Prevention 03/2016 Egil Lingaas Legionella Replicates at temperatures between 20 and 50 (45) oC Still water increases the risk of growth Water in buildings therefore at increased risk Oslo University Hospital Department of Infection Prevention 03/2016 Egil Lingaas 60 50 40 Publications on Legionella and “hospital” (medline) last 20 years 30 20 Number of publications of Number 10 0 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Oslo University Hospital N = 680 Department of Infection Prevention 03/2016 Egil Lingaas CID 2016:62 (1 February) • 273 Oslo University Hospital Department of Infection Prevention 03/2016 Egil Lingaas There are reasons to believe that Legionella is a small problem compared to other water-borne infections in hospitals Oslo University Hospital Department of Infection Prevention 03/2016 Egil Lingaas Rutala WA: Infect Control Hosp Epidemiol 1997;1:609 Oslo
    [Show full text]
  • Antigenic Heterogeneity Among Legionella, Fluoribacter, and Tatlockia Species Analyzed by Crossed Immunoelectrophoresis
    INTERNATIONALJOURNAL OF SYSTEMATICBACTERIOLOGY, Oct. 1987, p. 351-356 Vol. 37, No. 4 0020-7713/87/040351-06$02.00/0 Copyright 0 1987, International Union of Microbiological Societies Antigenic Heterogeneity Among Legionella, Fluoribacter, and Tatlockia Species Analyzed by Crossed Immunoelectrophoresis MICHAEL T. COLLINS,l* JETTE M. BANGSBORG,2 AND NIELS H@IBY2 Department of Pathobiological Sciences, University of Wisconsin, Madison, Wisconsin 53706’ and State Serum Institute, Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark2 Crossed immunoelectrophoresis (XIE) reference systems were established for Fluoribacter (Legionella) (containing Fluoribacter bozemanae, Fluoribacter dumofii, and Fluoribacter gormanii) and for Tatlockia (Legionella) micdadei. The Fluoribacter and Tatlockia XIE reference systems contained 54 and 72 anode- migrating antigens, respectively. These two systems, together with the previously described polyvalent Legionella pneumophila (serogroups 1 through 6) XIE reference system, were used to study the cross- reactivities of antigens from organisms comprising the three proposed genera in the family Legionellaceae. Antigenic homology was expressed as the matching coefficient (MC), the ratio of the number of cross-reactive antigens to the total number of antigens. The MCs for individual L. pneumophila serogroups when the polyvalent L. pneumophila antibody was used were 0.98 f 0.05, which was significantly higher than the MCs determined by using Fluoribacter or Tatlockia antibodies (0.50 f 0.13) (P < 0.001). The MCs for the three species of Fluoribacter when polyvalent Fluoribacter antibody was used were 0.93 & 0.10, which was also significantly higher than the MCs when heterologous antibodies were used (0.40 f 0.04) (P< 0.001). The MCs for T.
    [Show full text]
  • Agglutinating Antibody Titers to Members of the Family Reacting Antibodies to Pseudomonas Aeruginosa
    JOURNAL OF CLINICAL MICROBIOLOGY, June 1984, P. 757-762 Vol. 19, No. 6 0095-1137/84/060757-06$02.00/0 Copyright C 1984, American Society for Microbiology Agglutinating Antibody Titers to Members of the Family Legionellaceae in Cystic Fibrosis Patients as a Result of Cross- Reacting Antibodies to Pseudomonas aeruginosa MICHAEL T. COLLINS,lt* JEANNETTE McDONALD, NIELS H0IBY,2 AND OLE AALUND3 Department of Microbiology and Environmental Health, Colorado State University, Fort Collins, Colorado 805231; and Statens Seruminstitut, Department of Clinical Microbiology, and Pediatric Department TG, Rigshospitalet,2 and Laboratory of Preventive Medicine, Royal Veterinary and Agriculture College,3 Copenhagen, Denmark Received 6 October 1983/Accepted 9 March 1984 The objective of this study was to evaluate the prevalence and significance of antibody titers to organisms in the family Legionellaceae in 128 serum samples collected from cystic fibrosis patients at routine examinations. Antibody titers were determined for 10 antigenic types of Legionellaceae; Legionella pneumophila serogroups 1 to 6, Fluoribacter (Legionella) bozemanae, Fluoribacter (Legionella) dumoffii, Fluoribacter (Legionella) gormanii, and Tatlockia (Legionella) micdadei. The method of antibody titer determination was the microagglutination test. Elevated titers (.1:64) to one or more antigens were found in 41.3% of cystic fibrosis patients but in only 9.7% of 103 normal control subjects (P < 0.01). Titers to 8 of the 10 antigens were directly correlated with the number ofPseudomonas aeruginosa precipitating antibodies in patient sera, as determined by crossed immunoelectrophoresis (correlation coefficients, -0.74). Cross- reactions between P. aeruginosa and L. pneumophila were substantiated by crossed immunoelectrophore- sis of hyperimmune rabbit serum as well as patient sera against P.
    [Show full text]